ѻý

Skip to content

Devastated: Island girl's mom speaks out on last day of B.C.-funded treatment

The province says 9-year-old Charleigh Pollock no longer meets the criteria for the drug Brineura
250619charleighpollock
Nine-year-old Charleigh Pollock is all smiles on the last day (June 19) she receives the drug Brinuera, funded by the province.

Shock, devastation, sadness and fear are some of the many emotions the family of Langford girl Charleigh Pollock have experienced in the 24 hours after they received the news the province is pulling funding for treatment of the nine-year-oldѻýs terminal illness.

ѻýItѻýs a roller-coaster,ѻý says mom Jori Fales, speaking to Goldstream Gazette June 19 from Victoria General Hospital, the day her daughter received her last province-funded infusion of the drug Brineura.

ѻýToday the feeling is anger.ѻý

Pollock is the only child in B.C. living with the rare genetic disorder Batten disease. She has been receiving the bi-weekly enzyme replacement treatment, funded by the province for nearly six years, costing around $1 million a year.

The day before Pollockѻýs last infusion treatment, the Ministry of Health said June 18 it would be standing by a decision made in February that the nine-year-old no longer meets the criteria to receive Brineura.

Fales says she only found out about the decision from her daughterѻýs physician minutes before she received a flurry of messages from journalists, offering the family their condolences.

ѻýIt's sad to know that there was already a press conference planned before the family was even informed ѻý itѻýs all been very impersonal,ѻý she said, adding that she has never spoken to anyone from the Ministry of Health, including Health Minister Josie Osborne.

250619charleighjori
Charleigh with her mom Jori Fales on June 19 ѻý the last day the nine-year-old will receive province-funded drug Brineura for her terminal illness. Courtesy of Jori Fales

Intended to slow the progression of the disease, Brineura has given Pollock a life free from daily seizures, says Fales.

However, a review by Canadaѻýs Drug Agency (CDA), found ѻýinsufficient evidenceѻý to make definitive conclusions about the potential benefits of the drug on quality of life, seizure control, and mortality outcomes.

The ministry has also made it clear Brineura is not an anti-seizure medication.

The CDAѻýs review also found no new evidence that justified changing the discontinuation criteria for Brineura, first established in 2019 ѻý something mom Fales has described as "outdated."

Ultimately, the Expensive Drugs for Rare Diseases expert committees found the nine-year-oldѻýs condition meets the discontinuation criteria.

ѻýMeaning there was no evidence to support the ministry continuing to provide coverage for Brineura, given the advanced stage of Charleighѻýs condition,ѻý said a statement by Osborne.

Fales says hearing the minister talk about her daughterѻýs condition made her ѻýblood boil.ѻý

ѻýI need people to know she is not in an advanced state of her disease, and she is in a stabilized position due to her medication that she's been receiving,ѻý she said. ѻýCharleigh hasn't had seizures in years.ѻý

With her final dose of Brineura now complete, Pollockѻýs future is uncertain, says Fales, who disagrees with the ministry that the drug is not effective in managing her daughterѻýs seizures.

ѻýUnfortunately, time will tell, and everyone is going to see exactly what's going to happen to Charleigh once this medication is removed,ѻý said Fales. ѻýShe's being made an example, and it's unfortunate.ѻý

She says the timeline for her daughterѻýs life expectancy has now been ѻýexceptionally speeded up.ѻý

ѻýAnd it wasn't even our choice,ѻý says Fales, who believes Pollockѻýs medical team should have been at the forefront of the decision-making process.

ѻýThey still recommend she continues to receive treatment.ѻý

Following the news, the family has been met with a wave of support from the public. Hundreds of comments online from folks expressing disbelief at the ministryѻýs decision.

The family of Oak Bay's Simon Hoskins, who lives with the rare progressive disease mucopolysaccharidosis (MPS) Type IV, has also spoken out in support.

Like Pollock, Hoskins receives province-funded treatment ѻý a synthetic enzyme infusion that helps slow the progression of his disease, allowing him ѻýto retain the best quality of life possible.ѻý

ѻý(Charleigh) and her family deserve so much more, we are holding them close as the news hits so very hard today,ѻý the Hoskins family wrote in an emotional Instagram post.

MLA for CourtenayѻýComox and opposition critic for rural and seniors health Brennan Day has also slammed the provinceѻýs decision, calling it ѻýmorally indefensible.ѻý

ѻýItѻýs appalling that this government believes recreational drug programs are a higher priority than giving a young girl a fighting chance,ѻý he said in a statement, calling on the province to immediately reverse the decision.

The public support has brought some comfort to Pollockѻýs family.

ѻýWe're just very grateful for everyone's support and love, and they're very appreciated,ѻý said Fales.

As for whatѻýs next for the family, Fales says they need time to process and accept what lies ahead.

ѻýAnd we'll continue to make Charleigh our priority,ѻý she said, explaining that her daughter has been shielded from what is happening.

ѻýJust like every day, she wakes up with a smile on her face and is a happy little girl ѻý today is no different.ѻý 



Ben Fenlon

About the Author: Ben Fenlon

Multimedia journalist with the Greater Victoria news team.
Read more